Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Primary Aldosteronism
NCT05924620Phase 4Completed
- Sponsor
- Chongqing Medical University
- Start
- Jun 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in primary aldosteronism (PA), sponsored by Chongqing Medical University. Started Jun 2023; status: completed.
02
Drugs
finerenone
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT05924620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05924620.